The following statement is attributable to:
Susan R. Bailey, M.D.
President, American Medical Association

“The recommendation approved today by the CDC Director for the use of the Moderna COVID-19 vaccine in the U.S. population is another major step toward vaccinating millions of people across the country. With a second vaccine soon hitting the market, we are on our way to gradually reducing the incidence of death and severe illness from COVID-19. The AMA applauds the FDA and its Vaccines and Related Biological Products Advisory Committee as well as the CDC and its Advisory Committee on Immunization Practices (ACIP) for continued transparency in the process for both authorization and recommended use of COVID-19 vaccines.

“As additional COVID-19 vaccines are developed and authorized for use in the U.S. over the coming months, the AMA will continue to monitor, and urge transparency during, the development, authorization, and allocation process. Thorough review and transparency are critical to ensuring people in the U.S. are ready and willing to take the vaccine. The AMA will also work to ensure physicians are aware of ACIP recommendations for use of all authorized COVID-19 vaccines, as well as their recommendations for prioritizing allocation of the vaccine.”

Media Contact:

Kelly Jakubek

ph: (312) 464-4443

[email protected]

About the American Medical Association

The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care.  The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.

Featured Stories